CapsoVision(CV.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
CapsoVision
CV.US
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. It offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). The company also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoAccess, a Capsule data access system; CapsoView, a data access reading device for viewing capsule videos; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. It serves gastrointestinal medical practices, clinics, and hospitals.
1.347 T
CV.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Insider-Owned Growth Stocks Poised For Success In January 2026

    As U.S. markets face rising Treasury yields and Federal Reserve uncertainty, insider activities are being closely monitored as indicators of company growth confidence. Stocks with high insider ownership, such as Super Micro Computer (SMCI) and Prairie Operating (PROP), are highlighted for their potential. Companies like CapsoVision and Harrow show promising earnings growth forecasts, with insider ownership suggesting strong management alignment. Upstart Holdings has seen significant insider buying, indicating confidence in its growth trajectory. The article emphasizes the importance of insider ownership in volatile market conditions.

    Simplywall·
    US
    CV
    -7.38%
    US
    SMCI
    -3.35%
    US
    HROW
    -2.36%
    Simplywall·
    US
    CV
    -7.38%
    US
    SMCI
    -3.35%
    US
    HROW
    -2.36%

    CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday

    U.S. stocks were mostly lower on Tuesday, with the Dow Jones index down over 0.1%. However, CapsoVision, Inc. (NASDAQ:CV) shares surged 8.4% to $12.55 after submitting a 510(k) application to the FDA for its AI-assisted module. Other notable gainers included AXT, Inc. (+13.5%), Ultragenyx Pharmaceutical Inc. (+13.6%), and Greenwich LifeSciences, Inc. (+13.6%). ACM Research, Inc. also saw a 6.2% increase, with plans to release revenue forecasts in January 2026.

    benzinga_article·
    US
    ACMR
    +6.29%
    US
    CV
    -7.38%
    US
    GLSI
    +0.17%
    benzinga_article·
    US
    ACMR
    +6.29%
    US
    CV
    -7.38%
    US
    GLSI
    +0.17%

    CapsoVision Submits 510(k) Application for AI-Assisted Capsule Endoscopy Module

    CapsoVision Inc. has submitted a 510(k) application to the FDA for an AI-assisted reading module for its CapsoCam Plus® capsule endoscopy system. This module aims to improve the detection of significant pathology and decrease clinician review time. CapsoVision intends to begin U.S. commercialization after receiving FDA clearance.

    Reuters·
    US
    CV
    -7.38%
    Reuters·
    US
    CV
    -7.38%

    CapsoVision (NASDAQ:CV) Trading Down 6.5% - Here's Why

    CapsoVision, Inc. (NASDAQ:CV) shares fell 6.5% on Friday, trading as low as $12.90. The trading volume was significantly lower than average. Analysts have mixed ratings on the stock, with a consensus rating of 'Moderate Buy' and a target price of $6.00. The company reported a quarterly loss, missing estimates. An institutional investor recently acquired shares, and CapsoVision specializes in capsule endoscopy systems.

    Market Beat·
    US
    CV
    -7.38%
    Market Beat·
    US
    CV
    -7.38%

    Pre-market hot trades in US stocks: CapsoVision pre-market down 8.17%; RYTHM pre-market down 6.26%

    CapsoVision pre-market down 8.17%; RYTHM pre-market down 6.26%; Dongfang Culture pre-market up 61.45%; AMC Robotics pre-market up 52.40%; cbdMD pre-market up 35.83%

    Tracking Unusual Activity·
    US
    CV
    -7.38%
    US
    RYM
    -8.93%
    Tracking Unusual Activity·
    US
    CV
    -7.38%
    US
    RYM
    -8.93%
    © 2026 Longbridge｜Disclaimer